Overview

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
This is an on-going study to evaluate the long-term safety and maintenance of effect of duloxetine in patients suffering with stress urinary incontinence.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride